Mylan’s Morgantown plant is restarting production of an anti-malaria medication that is under study as a potential treatment for the COVID-19 virus.

Corona Virus Treatment

Our comments; they would not be doing this unless people were buying. Additionally, people would not be buying if the didn't think it would work. Another global supply chain shortened.

"The drug had been in short supply earlier in March, according to news reports, but Mylan and another generic drug firm, Israel-based Teva, are both ramping up production."

Be the first to comment

Please check your e-mail for a link to activate your account.